Multiple myeloma Total Therapy trial patient sequencing

Dataset ID Technology Samples
EGAD00001004373 NextSeq 500 263

Dataset Description

DNA was obtained from either CD138+ cells from the bone marrow of multiple myeloma patients (tumor) or from stem cell harvests or peripheral blood cells from the same patient (control). 100 ng of DNA was fragmented, end-repaired, and adapters ligated using the HyperPlus kit (KAPA Biosystems). After PCR amplification the libraries were hybridized with probes against either a targeted panel consisting of 140 genes and chromosomal regions (Nimblegen) using SeqCap reagents (Nimblegen). Hybridized libraries underwent further amplification before being sequenced on a NextSeq500 (Illumina) using 75 bp paired end reads.

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

UAMS - Myeloma Institute Data Access Committee
Contact person: Gareth Morgan
Email: gareth [dot] morgan [at] nyulangone [dot] org
More details: EGAC00001000845


You don't have access to the download section.